How do antidepressants affect prolactin levels?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Antidepressants and Prolactin Levels

Antidepressants can cause hyperprolactinemia, though this effect varies significantly by drug class, with selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) being most commonly associated with elevated prolactin levels. 1

Mechanism of Action

Antidepressants may elevate prolactin levels through several mechanisms:

  1. Serotonergic pathway interference: Antidepressants, particularly SSRIs, increase serotonin levels which can indirectly inhibit dopamine release in the tuberoinfundibular pathway 1

  2. Dopamine antagonism: Some antidepressants have mild dopamine receptor blocking properties that can reduce dopamine's inhibitory effect on prolactin secretion 1

  3. Indirect modulation: Serotonin can stimulate GABAergic neurons, which in turn may affect prolactin release 1

Incidence and Clinical Significance

  • Most antidepressants have been reported to cause hyperprolactinemia, though symptoms are rare 1
  • The incidence rates are not clearly established in the literature
  • When hyperprolactinemia does occur, it can lead to:
    • Galactorrhea (abnormal milk production)
    • Menstrual disturbances
    • Sexual dysfunction
    • Decreased bone mineral density (with long-term elevation)
    • Potential infertility 2

Antidepressant Classes and Prolactin Effects

SSRIs

  • Most commonly associated with hyperprolactinemia among antidepressants
  • Cases of galactorrhea have been reported with escitalopram even with normal prolactin levels (euprolactinemic galactorrhea) 3

SNRIs

  • Can cause hyperprolactinemia but generally less frequently than SSRIs

Other Antidepressants

  • Tricyclic antidepressants and MAOIs have less consistent effects on prolactin

Risk Factors and Potentiating Conditions

  • Female gender: Women appear more susceptible to antidepressant-induced hyperprolactinemia 4
  • Combination therapy: Co-administration of antidepressants with other medications can increase the risk:
    • Antidepressants + benzodiazepines may potentiate hyperprolactinemia 5, 4
    • Antidepressants + low-dose antipsychotics (e.g., risperidone 0.5-2mg) significantly increase prolactin levels 5

Monitoring and Management

When hyperprolactinemia is suspected in patients taking antidepressants:

  1. Measure serum prolactin levels if symptoms such as galactorrhea, menstrual irregularities, or sexual dysfunction occur 1

  2. Management options:

    • Change to an antidepressant less likely to affect prolactin levels
    • Consider using the lowest effective dose of the antidepressant
    • In severe cases, dopamine agonists like cabergoline may be considered, though this requires careful monitoring 6, 7
  3. Routine monitoring of prolactin levels in asymptomatic patients on antidepressants is not recommended 1

Important Caveats

  • Hyperprolactinemia symptoms may be subtle or absent despite elevated levels
  • When evaluating elevated prolactin, rule out other causes (pituitary tumors, hypothyroidism, pregnancy)
  • Antipsychotics (particularly first-generation and risperidone) cause much more significant hyperprolactinemia than antidepressants 2
  • If dopamine agonist therapy (like cabergoline) is needed for persistent symptomatic hyperprolactinemia, start with low doses (0.25mg twice weekly) and monitor closely 7, 8

In conclusion, while antidepressant-induced hyperprolactinemia is possible, it is generally less common and less severe than that caused by antipsychotics. Clinicians should be aware of this potential side effect and evaluate prolactin levels when relevant symptoms occur in patients taking antidepressants.

References

Research

Antipsychotic-induced hyperprolactinemia.

Pharmacotherapy, 2009

Research

A case with euprolactinemic galactorrhea induced by escitalopram.

International journal of psychiatry in medicine, 2007

Research

Hyperprolactinemia after low dose of amisulpride.

Neuro endocrinology letters, 2004

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Hyperprolactinemia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.